Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in Atrial Fibrillation (BRAIN-AF): Methods and Design

Léna Rivard(Government of the Republic of Korea), Denis Roy(Montreal Heart Institute), Jeff S. Healey(Population Health Research Institute), Marie‐Claude Guertin, Bernard Thibault(Montreal Heart Institute), Isabelle Nault(Institut universitaire de cardiologie et de pneumologie de Québec), Rafik Tadros(Montreal Heart Institute), George Wyse(University of Calgary), Normand Racine(Montreal Heart Institute), Simon Kouz, Louis Bherer, Sandra E. Black(Sunnybrook Health Science Centre), Laurent Macle(Montreal Heart Institute), Paul Khairy(Montreal Heart Institute), Fadi Massoud(Centre Hospitalier de l’Université de Montréal), Jean‐Claude Tardif(Montreal Heart Institute), Katia Dyrda, Jean-François Roux, Sylvain Lanthier(Hôpital du Sacré-Cœur de Montréal), Blandine Mondésert(Montreal Heart Institute), Stanley Nattel(Montreal Heart Institute), Kenneth A. Ellenbogen(Virginia Commonwealth University), Vidal Essebag(McGill University Health Centre), Julia Cadrin‐Tourigny(Montreal Heart Institute), Peter G. Guerra(Montreal Heart Institute), Jason G. Andrade(Heart Rhythm Society), Paul Dorian(St. Michael's Hospital), Isabelle Greiss(Université de Montréal), Mario Talajic(Montreal Heart Institute), Marc Dubuc(Montreal Heart Institute), Hélène Mayrand

Canadian Journal of Cardiology

May 8, 2019

Cited by 40

|The Lancet Neurology|2013|5.4k

|New England Journal of Medicine|2018|3.2k

|Heart Rhythm|2017|2.7k

|New England Journal of Medicine|2015|2.3k

|New England Journal of Medicine|2012|2.1k

Related Papers